Scientists have identified new gene faults and evolutionary patterns contributing to testicular cancer. Their findings offer ...

Scientists have identified new gene faults and evolutionary patterns contributing to testicular cancer. Their findings offer profound insights into the development of the disease and into potential ...

More than half of midlands-based cancer patients whose genomes were successfully sequenced through the 100,000 Genomes ...

The MI Cancer Seek in vitro diagnostic examines genetic material isolated from standard tumor tissue specimens and queries ...

Compared to DNA sequencing alone, concurrent DNA and RNA sequencing revealed more clinically actionable variants in NSCLC.

More than half of midlands-based cancer patients whose genomes were successfully sequenced through the 100,000 Genomes Project.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

More than half of midlands-based cancer patients whose genomes were successfully sequenced through the 100,000 Genomes ...

With whole-genome sequencing and computational tools, the researchers identified genetic mutations and structural variations ...

The treatment landscape for patients with prostate cancer, especially individuals with advanced disease, has dramatically ...

Researchers analyzed whole-genome sequencing data from 76,805 patients to identify variants in 4 genes that are associated ...

CODA, the first ever 3D genome profiling technique, was able to make a 3D print of pre-cancerous cells found in a human ...